Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
- PMID: 32160729
- PMCID: PMC7160349
- DOI: 10.3350/cmh.2020.0042
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
Keywords: Alcoholic liver disease; Hepatocellular carcinoma; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Surveillance.
Conflict of interest statement
The author has no conflicts to disclose.
Comment on
-
Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.Clin Mol Hepatol. 2020 Apr;26(2):196-208. doi: 10.3350/cmh.2019.0012. Epub 2020 Jan 9. Clin Mol Hepatol. 2020. PMID: 31914720 Free PMC article.
References
-
- Global Burden of Disease Liver Cancer Collaboration. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. the burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3:1683–1691. - PMC - PubMed
-
- Dyson J, Jaques B, Chattopadyhay D, Lochan R, Graham J, Das D, et al. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J Hepatol. 2014;60:110–117. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
